Accelerating and Optimizing a Pharmaceutical Company's Time to Market: The R-Pharm and QuintilesIMS Partnership

How can a partnership between a drug sponsor and a development partner improve the efficiency of bringing a product to market?
Lorraine Marchand, Adrian McKemey, Dr. Mikhail Samsonov  | Winter 2017
Print this page
R-Pharm is a vertically integrated pharmaceutical firm based in Russia, serving established and emerging markets. QuintilesIMS is a transnational CRO that began as a biostatistical consulting company serving the pharmaceutical industry that has expanded into data management and monitoring of clinical trials. This case tells the story of the partnership between these two companies that brought the drug olokizumab to market efficiently and successfully.

Case ID: 170406

Buy select cases through Ivey Publishing and Harvard Business Publishing.

 

Contact us by e-mail at Columbia CaseWorks or 212-854-1796.